Genes in panel
STRs in panel
Prev Next

COVID-19 research

Gene: IL6

Green List (high evidence)

IL6 (interleukin 6)
EnsemblGeneIds (GRCh38): ENSG00000136244
EnsemblGeneIds (GRCh37): ENSG00000136244
OMIM: 147620, Gene2Phenotype
IL6 is in 6 panels

2 reviews

Sophie Hambleton (Newcastle University)

Green List (high evidence)

Given importance of IL6 to severe COVID pathogenesis I think it makes sense to consider variants within it, including eQTLs that affect its expression (implies importance of including regulatory regions within targeted virtual panel)
Created: 7 May 2020, 4:20 p.m. | Last Modified: 7 May 2020, 4:20 p.m.
Panel Version: 0.204

Sarah Leigh (Genomics England Curator)

Green List (high evidence)

Preprint https://doi.org/10.1101/2020.05.02.20084673 reports 10 terminally-ill, critical COVID-19 patients with profound elevation of plasma IL-6 and CCL5 (RANTES), decreased CD8+ T cell levels, and SARS-CoV-2 plasma viremia. Treatment with CCR5 blocking antibody leronlimab, results in complete CCR5 receptor occupancy on macrophage and T cells, rapid reduction of plasma IL-6, restoration of the CD4/CD8 ratio, and a significant decrease in SARS-CoV-2 plasma viremia. From single-cell RNA-sequencing, this effect appears to be a result of reduced transcriptomic myeloid cell clusters expressing IL-6 and interferon-related genes.
Created: 11 May 2020, 3:18 p.m. | Last Modified: 11 May 2020, 3:18 p.m.
Panel Version: 0.204
Strong association was observed between an IL6 promoter polymorphism (G-174C) and susceptibility to Kaposi Sarcoma (KS) in HIV-infected men (P?=?.0035). Homozygotes for IL6 allele G, associated with increased IL6 production, were over represented among patients with KS (P?=?.0046), whereas allele C homozygotes were under represented (P?=?.0062)(PMID 11001912).
Created: 4 May 2020, 3:17 p.m. | Last Modified: 5 May 2020, 8:14 a.m.
Panel Version: 0.179

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Phenotypes
{Kaposi sarcoma, susceptibility to} 148000

Publications

  • https://doi.org/10.1101/2020.05.02.20084673

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
Sources
  • Expert Review Green
  • OMIM
Phenotypes
  • {Kaposi sarcoma, susceptibility to} 148000
OMIM
147620
Clinvar variants
Variants in IL6
Penetrance
None
Publications
  • https://doi.org/10.1101/2020.05.02.20084673
Panels with this gene

History Filter Activity

15 Jun 2020, Gel status: 3

Set Phenotypes

Sarah Leigh (Genomics England Curator)

Phenotypes for gene: IL6 were changed from to {Kaposi sarcoma, susceptibility to} 148000

15 Jun 2020, Gel status: 3

Set publications

Sarah Leigh (Genomics England Curator)

Publications for gene: IL6 were set to

15 Jun 2020, Gel status: 3

Set mode of inheritance

Sarah Leigh (Genomics England Curator)

Mode of inheritance for gene: IL6 was changed from to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

11 May 2020, Gel status: 3

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: il6 has been classified as Green List (High Evidence).

5 May 2020, Gel status: 2

Entity classified by Genomics England curator

Sarah Leigh (Genomics England Curator)

Gene: il6 has been classified as Amber List (Moderate Evidence).

21 Apr 2020, Gel status: 1

Created, Added New Source, Set mode of inheritance

Sarah Leigh (Genomics England Curator)

gene: IL6 was added gene: IL6 was added to Viral susceptibility. Sources: OMIM Mode of inheritance for gene: IL6 was set to